HK1212210A1 - Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3 - Google Patents

Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3

Info

Publication number
HK1212210A1
HK1212210A1 HK16100085.8A HK16100085A HK1212210A1 HK 1212210 A1 HK1212210 A1 HK 1212210A1 HK 16100085 A HK16100085 A HK 16100085A HK 1212210 A1 HK1212210 A1 HK 1212210A1
Authority
HK
Hong Kong
Prior art keywords
vitamin
hydroxy
combined use
combined
Prior art date
Application number
HK16100085.8A
Other languages
English (en)
Chinese (zh)
Inventor
尼爾‧羅伯特‧巴克
沃特‧克雷豪
布魯諾‧
‧勒安伯格
伊麗莎白‧斯達克林
凱‧爾本
斯文‧沃爾夫拉姆
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of HK1212210A1 publication Critical patent/HK1212210A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
HK16100085.8A 2008-02-13 2016-01-06 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3 HK1212210A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2851008P 2008-02-13 2008-02-13
US3167108P 2008-02-26 2008-02-26
US3692208P 2008-03-14 2008-03-14
US3692808P 2008-03-15 2008-03-15

Publications (1)

Publication Number Publication Date
HK1212210A1 true HK1212210A1 (en) 2016-06-10

Family

ID=40551383

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100085.8A HK1212210A1 (en) 2008-02-13 2016-01-06 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3

Country Status (12)

Country Link
US (1) US20110039809A1 (ja)
EP (1) EP2240181A1 (ja)
JP (1) JP5509504B2 (ja)
KR (2) KR20150103336A (ja)
CN (2) CN101951919A (ja)
AU (1) AU2009214052B2 (ja)
BR (1) BRPI0907951A2 (ja)
EA (1) EA018580B1 (ja)
HK (1) HK1212210A1 (ja)
IL (1) IL207592A0 (ja)
MX (1) MX2010008906A (ja)
WO (1) WO2009101135A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
PL1993559T3 (pl) 2006-02-03 2017-01-31 Opko Renal, Llc Leczenie niedoboru i deficytu witaminy d z zastosowaniem 25-hydroksywitaminy d2 i 25-hydroksywitaminy d3
LT2679228T (lt) 2006-06-21 2018-05-10 Opko Ireland Global Holdings, Ltd. Terapija naudojant vitamino d atstatymo agentą ir vitamino d hormoninį pakaitinį agentą
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
WO2008134512A1 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
US20110052707A1 (en) * 2008-02-12 2011-03-03 Neil Robert Buck Combination of vitamin d and 25-hydroxyvitamin d 3
IT1393945B1 (it) * 2009-04-21 2012-05-17 Fidia Farmaceutici Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche
KR102125424B1 (ko) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 부갑상선 수준을 낮추기 위한 방법 및 조성물
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
RU2497533C1 (ru) * 2012-04-19 2013-11-10 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CR20170085A (es) 2014-08-07 2017-04-25 Opko Ireland Global Holdings Ltd Terapia adjuntiva con 25-hidroxi vitamina d
DK3090638T3 (da) * 2015-04-20 2020-08-10 Bernd-Michael Löffler Kosttilskud til behandling af vitamin-d3-mangelsymptomer
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
AU2017330451B2 (en) * 2016-09-23 2022-01-20 Quincy Bioscience, Llc Apoaequorin and vitamin D-containing compositions and methods of using same
CN110338425A (zh) * 2018-04-08 2019-10-18 北京奥萨医药研究中心有限公司 一种防护骨质疏松的营养补充剂
CN108720025A (zh) * 2018-06-08 2018-11-02 唐飞 25-羟基维生素d3在食品中的应用
CN108902985A (zh) * 2018-06-08 2018-11-30 唐飞 25-羟基维生素d3在制备保健食品中的应用
IT201900007202A1 (it) * 2019-05-24 2020-11-24 Pavia Farm S R L Composizione a base di vitamine liposolubili ad elevato assorbimento enterico
WO2022224001A1 (en) * 2021-04-22 2022-10-27 Faes Farma, S.A. Universal dosage regime of 25-hydroxy vitamin d3
CN114088855B (zh) * 2021-11-16 2022-10-28 河南农业大学 一种肉鸡胫骨软骨发育不良早期诊断粪便生物标志物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US7050832B2 (en) * 2001-11-28 2006-05-23 Arraycomm Llc Variable diversity transmission in a radio communications system based on characteristics of a received signal
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
ES2392823T3 (es) * 2003-09-22 2012-12-14 Dsm Ip Assets B.V. Uso de compuestos de vitamina D
US20070082089A1 (en) * 2003-09-22 2007-04-12 Stephanie Krammer Vitamin containing pet food compositions
KR20140105873A (ko) * 2005-08-18 2014-09-02 디에스엠 아이피 어셋츠 비.브이. 수컷 동물의 번식력을 향상시키는데 있어서의 25-하이드록시 비타민 ｄ₃의 용도
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
DE602006016005D1 (de) * 2005-11-25 2010-09-16 Dsm Ip Assets Bv Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren
PL1993559T3 (pl) * 2006-02-03 2017-01-31 Opko Renal, Llc Leczenie niedoboru i deficytu witaminy d z zastosowaniem 25-hydroksywitaminy d2 i 25-hydroksywitaminy d3

Also Published As

Publication number Publication date
CN101951919A (zh) 2011-01-19
KR20150103336A (ko) 2015-09-09
US20110039809A1 (en) 2011-02-17
JP5509504B2 (ja) 2014-06-04
EA201001286A1 (ru) 2010-12-30
KR20100126376A (ko) 2010-12-01
AU2009214052A1 (en) 2009-08-20
EA018580B1 (ru) 2013-09-30
JP2011512343A (ja) 2011-04-21
MX2010008906A (es) 2010-11-05
EP2240181A1 (en) 2010-10-20
IL207592A0 (en) 2010-12-30
BRPI0907951A2 (pt) 2015-08-04
AU2009214052B2 (en) 2015-05-07
CN104758301A (zh) 2015-07-08
WO2009101135A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
HK1212210A1 (en) Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3
IL256924B (en) Prebiotic formulations and methods of using them
IL207589A0 (en) Combination of vitamin d and 25-hydroxyvitamin d3
GB2467610B (en) Elevator and method of use
HK1148686A1 (en) Vitamin e derivatives and their uses
EP2432492A4 (en) APPLICATION AND USE OF PRG4 AND THERAPEUTIC MODULATION THEREOF
HK1172896A1 (zh) 化合物和使用方法
HK1161094A1 (en) Compounds and methods of use
EP2579831A4 (en) DONATION AND APPLICATION PROCEDURE
IL209855A0 (en) Supression of neuroedocrine diseases
EP2516555A4 (en) COLORING AGENT AND METHOD FOR USE THEREOF
EP2461691A4 (en) THERAPEUTIC VITAMIN D SUNSCREEN FORMULATIONS AND METHOD OF USE THEREOF
HK1149933A1 (en) Diazacarbazoles and methods of use
PL2249842T3 (pl) Zastosowanie 25-hydroksy-witaminy D3 i witaminy D do oddziaływania na fizjologię ludzkich mięśni
IL209548A0 (en) Diazacarbazoles and methods of use
IL219155A0 (en) Pharmaceutical formulations of nitrite and uses thereof
IL199924A0 (en) Extended relase formulation of nevirapine
HK1160925A1 (zh) 組織蛋白酶 的用途
HK1139411A1 (en) Hydroxy sulfonate of quinone compounds and their uses
IL206577A0 (en) Formulations of flibanserin
ZA201102857B (en) Anti-infective formulation and methods of use
IL224191A (en) Compositions of vitamin d and cmc epi-14 analogues
EP2358693A4 (en) PREPARATION OF DOCETAXEL
ZA201004979B (en) Extracts of sclerocarya birrea
HK1131039A1 (en) Pharmaceutical use of sophoricoside